ChemWerth
Private Company
Funding information not available
Overview
Established in 1982 by Peter Werth, ChemWerth is a family-owned, global leader in the generic API sector, offering end-to-end services from product development to commercial supply. The company leverages exclusive partnerships with over 30 manufacturing facilities across the U.S., Europe, India, and China, and boasts a track record of over 550 worldwide regulatory approvals. Its core value proposition is enabling customers to reach the market faster through integrated technical, analytical, and regulatory support, with a focus on complex molecules, oncologicals, and antibiotics.
Technology Platform
ChemWerth's platform is an integrated service network for generic API development and supply, featuring an FDA-approved lab, a global cGMP manufacturing partnership network, and a regulatory team with over 550 worldwide approvals.
Opportunities
Risk Factors
Competitive Landscape
ChemWerth competes with large integrated API manufacturers (e.g., Dr. Reddy's, Aurobindo, Huahai) and specialized suppliers. Its main differentiation is its full-service, U.S.-based partnership model with deep regulatory expertise and a quality-audited global network, appealing to customers seeking cost-effective supply with robust regulatory support and supply chain security.